Area of research
Immunology · Oncology
Research interest
Research interests include CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, and HIV Research and Treatment.
TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancers
TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen
Targeting a neoantigen derived from a common <i>TP53</i> mutation
Targeting public neoantigens for cancer immunotherapy
Bispecific antibodies targeting mutant<i>RAS</i>neoantigens
TCR β chain–directed bispecific antibodies for the treatment of T cell cancers
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
Author Correction: Targeting public neoantigens for cancer immunotherapy
Hallmarks of primate lentiviral immunodeficiency infection recapitulate loss of innate lymphoid cells
Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques
IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques
Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer